Antimicrobial Susceptibility Test Market By Product (Culture Media, Automated Test Systems, Tests And Kits), By Method (Rapid Automated Method, Broth Dilution Method, Disk Diffusion Method, Gradient Diffusion Method, Molecular Testing Method), By Test (Antifungal, Antibacterial, Antiparasitic), By Application (Clinical Diagnosis, Drug Discovery & Development) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published By: Brisk Insights | Published On: Aug 13, 2021

 

Industry Outlook

The antimicrobial susceptibility test market had market size of 2,755.9 Mn in 2017 and will grow at a CAGR 4.7% and is anticipated to reach 4,159.2 Mn in 2026. World Health Organization (WHO) has stipulated stringent guidelines to life science industry and agriculturists to judiciously use antibiotics. Rising prevalence of infectious disease and looming threat of superbug infection drives the antimicrobial susceptibility market growth. 

 

"Availability of diverse range of test kits and easy interpretation propel its market growth"

 

Tests and Kits are presently reigning the product segment for antimicrobial susceptibility test market. Availability of diverse range of test kits and increasing health awareness regarding infectious disease resulting in early screening drive the tests and kits market growth. They are available as point of care diagnostic kits where in interpretation of results are quick and product is highly reliable and cost saving. There will be burgeoning requirement for culture media on account of flourishing biopharmaceutical industry and preservation of important cell lines and culture having therapeutic significance.

 

"Increasing demand from clinical and epidemiology applications drive the disk diffusion method"

 

In the current scenario the disk diffusion method lead the method segment for antimicrobial susceptibility test market owing to its ability to determine the therapeutic efficacy and sensitivity of antibiotics towards different strains of bacteria. Increasing demand from clinical and epidemiological applications drive the market growth for disk diffusion method. Broth dilution method is gaining huge traction from food industry segment due to its potential to detect infection caused by microbes such as E.coli and Enterococcus.

 

"Rising prevalence of infectious disease and increasing number of patients suffering with antimicrobial resistance propel the antibacterial test market growth"

 

In the present scenario antibacterial test are dominating the test segment for antimicrobial susceptibility test market. The primary factors responsible for its dominance are rising prevalence of bacterial infection and increasing number of patients suffering with antimicrobial resistance. Scientist are striving earnestly to develop broad spectrum antibiotics. Antiparasitic tests will gain huge traction during the forecast period on account of huge health burden caused by parasitic infections such as malaria, dengue and encephalitis etc.

 

"Increasing public health awareness regarding infectious disease propel the clinical diagnosis market growth"

 

Clinical diagnosis is currently leading the application segment for antimicrobial susceptibility test market. The major factors that propel the clinical diagnosis market growth are increasing public health awareness regarding infectious disease resulting in early screening. Huge investment spend by government healthcare agencies worldwide to provide effective diagnosis and precise treatment to curb the diagnosed infection. Drug discovery and development will showcase positive growth owing to the increasing threat caused by antibiotic resistance and rising demand for vaccines and biologics as a preventive measure against deadly infections.

 

"Rising prevalence of bacterial infection and increasing number of cases pertaining to antibiotic resistance will support the market growth in Asia Pacific region"

 

North America is leading the regional segment for antimicrobial susceptibility test market. According to the latest research citing presented by Center for Disease Control and Prevention (CDC) annually 2 million U.S. citizens are diagnosed with infectious disease resulting in death of approximately 25,000 people. Existence of well-developed healthcare infrastructure drive the market growth in North America. Supportive regulatory environment provided by European Medical Agency (EMA) and looming threat of antimicrobial resistance drive the market growth in Europe region. Asia Pacific serves as a lucrative market on account of rising prevalence of bacterial infection and burgeoning requirement for broad spectrum antibiotics to curb the spread of infectious diseases.

 

Historical & Forecast Period

 

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

 

Report Scope by Segments

 

The market segmentation for the report antimicrobial susceptibility test market is as follows:

 

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 By Product (2016-2026; US$ Mn)
 • Culture Media
 • Automated Test Systems
 • Tests and Kits

 By Method (2016–2026; US$ Mn)
 • Rapid Automated Method
 • Broth Dilution Method
 • Disk Diffusion Method
 • Gradient Diffusion Method
 • Molecular Testing Method

 By Test (2016–2026; US$ Mn)
 • Antifungal
 • Antibacterial
 • Antiparasitic

 By Application (2016–2026; US$ Mn)
 • Clinical Diagnosis
 • Drug Discovery & Development

 Geography Segment (2016–2026; US$ Mn)
 • North America (United States and Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

 

Pharmaceutical companies providing diagnostic kits for antimicrobial susceptibility test are Alifax Holding S.p.A., Bio-Rad Laboratories, Inc., bioMerieux, Biotron Healthcare, Becton Dickinson & Company, Danaher Corporation, HiMedia, Laboratories, Merck Group, Synbiosis and Thermo Fisher Scientific, Inc.

 

Key questions answered in this report

 

  • Who are the key pharmaceutical manufacturers providing antimicrobial susceptibility test kits?
  • What are the DRO’s pertaining to the antimicrobial susceptibility test market?
  • Which is the leading and fastest growing product segment for antimicrobial susceptibility test market?
  • Which is the leading and fastest growing method segment for antimicrobial susceptibility test market?
  • Which is the leading and fastest growing test segment for antimicrobial susceptibility test market?
  • Which is the leading and fastest growing application segment for antimicrobial susceptibility test market?
  • Which is the leading and fastest growing regional segment for antimicrobial susceptibility test market?

 

Chapter 1. Preface


1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

 

Chapter 2. Executive Summary


2.1. Global AST Market Portraiture
2.2. Global AST Market, by Product, 2017 (US$ Mn)
2.3. Global AST Market, by Method, 2017 (US$ Mn)
2.4. Global AST Market, by Test, 2017 (US$ Mn)
2.5. Global AST Market, by Application, 2017 (US$ Mn)
2.6. Global AST Market, by Geography, 2017 (US$ Mn)

 

Chapter 3. Antimicrobial Susceptibility Test (AST) Market: Dynamics and Future Outlook


3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global AST Market, by Key Players, 2017

 

Chapter 4. Global Antimicrobial Susceptibility Test (AST) Market, by Product


4.1. Overview
4.2. Culture Media
4.3. Automated Test Systems
4.4. Tests and Kits

 

Chapter 5. Global Antimicrobial Susceptibility Test (AST) Market, by Method


5.1. Overview
5.2. Rapid Automated Method
5.3. Broth Dilution Method
5.4. Disk Diffusion Method
5.5. Gradient Diffusion Method
5.6. Molecular Testing Method

 

Chapter 6. Global Antimicrobial Susceptibility Test (AST) Market, by Test


6.1. Overview
6.2. Antifungal
6.3. Antibacterial
6.4. Antiparasitic

 

Chapter 7. Global Antimicrobial Susceptibility Test (AST) Market, by Application


7.1. Overview
7.2. Clinical Diagnosis
7.3. Drug Discovery & Development

 

Chapter 8. Global Antimicrobial Susceptibility Test (AST) Market, by Geography


8.1. Overview
8.2. North America AST Market Analysis, 2016 – 2026
8.2.1. North America AST Market, by Product, 2016 – 2026 (US$ Mn)
8.2.2. North America AST Market, by Method, 2016 – 2026 (US$ Mn)
8.2.3. North America AST Market, by Test, 2016 – 2026 (US$ Mn)
8.2.4. North America AST Market, by Application, 2016 – 2026 (US$ Mn)
8.2.5. North America AST Market, by Country, 2016 – 2026 (US$ Mn)
8.2.5.1. U.S.
8.2.5.2. Canada
8.3. Europe AST Market Analysis, 2016 – 2026
8.3.1. Europe AST Market, by Product, 2016 – 2026 (US$ Mn)
8.3.2. Europe AST Market, by Method, 2016 – 2026 (US$ Mn)
8.3.3. Europe AST Market, by Test, 2016 – 2026 (US$ Mn)
8.3.4. Europe AST Market, by Application, 2016 – 2026 (US$ Mn)
8.3.5. Europe AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.3.5.1. U.K.
8.3.5.2. Germany
8.3.5.3. Rest of Europe
8.4. Asia Pacific AST Market Analysis, 2016 – 2026
8.4.1. Asia Pacific AST Market, by Product, 2016 – 2026 (US$ Mn)
8.4.2. Asia Pacific AST Market, by Method, 2016 – 2026 (US$ Mn)
8.4.3. Asia Pacific AST Market, by Test, 2016 – 2026 (US$ Mn)
8.4.4. Asia Pacific AST Market, by Application, 2016 – 2026 (US$ Mn)
8.4.5. Asia Pacific AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.4.5.1. China
8.4.5.2. Japan
8.4.5.3. Rest of Asia Pacific
8.5. Latin America AST Market Analysis, 2016 – 2026
8.5.1. Latin America AST Market, by Product, 2016 – 2026 (US$ Mn)
8.5.2. Latin America AST Market, by Method, 2016 – 2026 (US$ Mn)
8.5.3. Latin America AST Market, by Test, 2016 – 2026 (US$ Mn)
8.5.4. Latin America AST Market, by Application, 2016 – 2026 (US$ Mn)
8.5.5. Latin America AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.5.5.1. Brazil
8.5.5.2. Mexico
8.5.5.3. Rest of Latin America
8.6. Middle East and Africa AST Market Analysis, 2016 – 2026
8.6.1. MEA AST Market, by Product, 2016 – 2026 (US$ Mn)
8.6.2. MEA AST Market, by Method, 2016 – 2026 (US$ Mn)
8.6.3. MEA AST Market, by Test, 2016 – 2026 (US$ Mn)
8.6.4. MEA AST Market, by Application, 2016 – 2026 (US$ Mn)
8.6.5. MEA AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.6.5.1. GCC
8.6.5.2. Rest of MEA

 

Chapter 9. Company Profiles


9.1. Alifax Holding S.p.A.
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Product Portfolio
9.1.4. News Coverage
9.2. Bio-Rad Laboratories, Inc.
9.3. bioMerieux
9.4. Biotron Healthcare
9.5. Becton Dickinson & Company
9.6. Danaher Corporation
9.7. HiMedia Laboratories
9.8. Merck Group
9.9. Synbiosis
9.10. Thermo Fisher Scientific, Inc.

AST - Antimicrobial Susceptibility Test

TABLE 1 Global Antimicrobial Susceptibility Test (AST) Market Portraiture
TABLE 2 Global AST Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global AST Market , by Method, 2016 – 2026 (US$ Mn)
TABLE 4 Global AST Market , by Test, 2016 – 2026 (US$ Mn)
TABLE 5 Global AST Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 6 Global AST Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America AST Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 8 North America AST Market, by Method, 2016 – 2026 (US$ Mn)
TABLE 9 North America AST Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 10 North America AST Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 11 North America AST Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe AST Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 13 Europe AST Market, by Method, 2016 – 2026 (US$ Mn)
TABLE 14 Europe AST Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 15 Europe AST Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Europe AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific AST Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific AST Market, by Method, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific AST Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 20 Asia Pacific AST Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 21 Asia Pacific AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America AST Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 23 Latin America AST Market, by Method, 2016 – 2026 (US$ Mn)
TABLE 24 Latin America AST Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 25 Latin America AST Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 26 Latin America AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East and Africa AST Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 28 Middle East and Africa AST Market, by Method, 2016 – 2026 (US$ Mn)
TABLE 29 Middle East and Africa AST Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 30 Middle East and Africa AST Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 31 Middle East and Africa AST Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 32 Alifax Holding S.p.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 bioMerieux: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Biotron Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Becton Dickinson & Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 HiMedia Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 39 Merck Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 40 Synbiosis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 41 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

FIG. 1 Antimicrobial Susceptibility Test (AST) Market: Research Methodology
FIG. 2 AST Market Segmentation
FIG. 3 Global AST Market, by Product, 2017 (US$ Mn)
FIG. 4 Global AST Market, by Method, 2017 (US$ Mn)
FIG. 5 Global AST Market, by Test, 2017 (US$ Mn)
FIG. 6 Global AST Market, by Application, 2017 (US$ Mn)
FIG. 7 Global AST Market, by Geography, 2017 (US$ Mn)
FIG. 8 Attractive Investment Proposition: by Geography, 2017
FIG. 9 Competitive Analysis: Global AST Market, by Key Players, 2017
FIG. 10 Global Culture Media Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 11 Global Automated Test Systems Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 12 Global Tests and Kits Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 13 Global Rapid Automated Method Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 14 Global Broth Dilution Method Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 15 Global Disk Diffusion Method Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 16 Global Gradient Diffusion Method Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 17 Global Molecular Testing Method Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 18 Global Antifungal Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 19 Global Antibacterial Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 20 Global Antiparasitic Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 21 Global Clinical Diagnosis Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 22 Global Drug Discovery & Development Market for Antimicrobial Susceptibility Test, 2016 – 2026 (US$ Mn)
FIG. 23 U.S. AST Market, 2016 – 2026 (US$ Mn)
FIG. 24 Canada AST Market, 2016 – 2026 (US$ Mn)
FIG. 25 U.K. AST Market, 2016 – 2026 (US$ Mn)
FIG. 26 Germany AST Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of Europe AST Market, 2016 – 2026 (US$ Mn)
FIG. 28 China AST Market, 2016 – 2026 (US$ Mn)
FIG. 29 Japan AST Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of Asia Pacific AST Market, 2016 – 2026 (US$ Mn)
FIG. 31 Brazil AST Market, 2016 – 2026 (US$ Mn)
FIG. 32 Mexico AST Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest of Latin America AST Market, 2016 – 2026 (US$ Mn)
FIG. 34 GCC AST Market, 2016 – 2026 (US$ Mn)
FIG. 35 Rest of MEA AST Market, 2016 – 2026 (US$ Mn)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)